ALNOV:EPA
Novacyt SA
0,41 €
0,00%
(0,00) 1K
6-noy, 17:35:21 (GMT+1) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoALNOV tikeri uchun statistika yaratilmoqda...
Ochish
0,41 €
Yuqori
0,41 €
Past
0,40 €
Bozor kapitali
27,19 mln
Oʻrtacha hajm
187,71 ming
Hajmi
119,78 ming
52 haftalik eng yuqori
1,04 €
52 haftalik eng past
0,29 €
Aksiya boʻyicha daromad
-0,38 €
Muomaladagi aksiyalar
72,59 mln
Xodimlar soni
228
Ochish
0,41 €
Yuqori
0,41 €
Past
0,40 €
Bozor kapitali
27,19 mln
Oʻrtacha hajm
187,71 ming
Hajmi
119,78 ming
52 haftalik eng yuqori
1,04 €
52 haftalik eng past
0,29 €
Aksiya boʻyicha daromad
-0,38 €
Muomaladagi aksiyalar
72,59 mln
Xodimlar soni
228
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
KTTC | Rochester, MN
·
1 kun oldin
A brutal sell-off for AI stocks sends Wall Street reeling; S&P 500 sees worst day since 2025 ‘Liberation Day’ tariffs
The Motley Fool
·
1 soat oldin
Democrats Just Swept Congress. Here's What History Says the S&P 500 Does Next.
Trefis
·
9 soat oldin
8 S&P 500 Stocks Just Made New 52-Week Highs
Barron's
·
1 kun oldin
S&P 500 Is Popping, but the Party Is Limited
Profil
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Novacyt SA haqida
CEODavid Allmond
Xodimlar soni228
Asos solingan3-iyl, 2006
Bosh ofislar-
SektorHealth Care
Soha-
Veb-saytnovacyt.com